These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 22650354

  • 1. Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine.
    Wahome N, Pfeiffer T, Ambiel I, Yang Y, Keppler OT, Bosch V, Burkhard P.
    Chem Biol Drug Des; 2012 Sep; 80(3):349-57. PubMed ID: 22650354
    [Abstract] [Full Text] [Related]

  • 2. Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.
    Matyas GR, Wieczorek L, Beck Z, Ochsenbauer-Jambor C, Kappes JC, Michael NL, Polonis VR, Alving CR.
    AIDS; 2009 Oct 23; 23(16):2069-77. PubMed ID: 19710597
    [Abstract] [Full Text] [Related]

  • 3. Interaction of anti-HIV type 1 antibody 2F5 with phospholipid bilayers and its relevance for the mechanism of virus neutralization.
    Maeso R, Huarte N, Julien JP, Kunert R, Pai EF, Nieva JL.
    AIDS Res Hum Retroviruses; 2011 Aug 23; 27(8):863-76. PubMed ID: 21142698
    [Abstract] [Full Text] [Related]

  • 4. Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.
    Zwick MB, Jensen R, Church S, Wang M, Stiegler G, Kunert R, Katinger H, Burton DR.
    J Virol; 2005 Jan 23; 79(2):1252-61. PubMed ID: 15613352
    [Abstract] [Full Text] [Related]

  • 5. N-terminal residues of an HIV-1 gp41 membrane-proximal external region antigen influence broadly neutralizing 2F5-like antibodies.
    Li D, Liu J, Zhang L, Xu T, Chen J, Wang L, Zhao Q.
    Virol Sin; 2015 Dec 23; 30(6):449-56. PubMed ID: 26715302
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a trimeric MPER containing HIV-1 gp41 antigen.
    Hinz A, Schoehn G, Quendler H, Hulsik DL, Stiegler G, Katinger H, Seaman MS, Montefiori D, Weissenhorn W.
    Virology; 2009 Aug 01; 390(2):221-7. PubMed ID: 19539967
    [Abstract] [Full Text] [Related]

  • 7. Multiple antigen peptide mimetics containing gp41 membrane-proximal external region elicit broad neutralizing antibodies against human immunodeficiency virus type 1 in guinea pigs.
    Zhang L, Miao L, Gong X, Zhang H, Yang L, Shi Y, Kong W, Jiang C, Shan Y.
    J Pept Sci; 2013 Aug 01; 19(8):491-8. PubMed ID: 23794478
    [Abstract] [Full Text] [Related]

  • 8. Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment.
    Luo M, Yuan F, Liu Y, Jiang S, Song X, Jiang P, Yin X, Ding M, Deng H.
    Vaccine; 2006 Jan 23; 24(4):435-42. PubMed ID: 16143433
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles.
    Phogat S, Svehla K, Tang M, Spadaccini A, Muller J, Mascola J, Berkower I, Wyatt R.
    Virology; 2008 Mar 30; 373(1):72-84. PubMed ID: 18155743
    [Abstract] [Full Text] [Related]

  • 10. Chemically modified peptides based on the membrane-proximal external region of the HIV-1 envelope induce high-titer, epitope-specific nonneutralizing antibodies in rabbits.
    Venditto VJ, Wieczorek L, Molnar S, Teque F, Landucci G, Watson DS, Forthal D, Polonis VR, Levy JA, Szoka FC.
    Clin Vaccine Immunol; 2014 Aug 30; 21(8):1086-93. PubMed ID: 24872518
    [Abstract] [Full Text] [Related]

  • 11. Selection and immune recognition of HIV-1 MPER mimotopes.
    Wieczorek L, Peachman K, Steers N, Schoen J, Rao M, Polonis V, Rao V.
    Virology; 2020 Nov 30; 550():99-108. PubMed ID: 32980676
    [Abstract] [Full Text] [Related]

  • 12. Human Rhinovirus Presenting 4E10 Epitope of HIV-1 MPER Elicits Neutralizing Antibodies in Human ICAM-1 Transgenic Mice.
    Yi G, Tu X, Bharaj P, Guo H, Zhang J, Shankar P, Manjunath N.
    Mol Ther; 2015 Oct 30; 23(10):1663-70. PubMed ID: 26061648
    [Abstract] [Full Text] [Related]

  • 13. An affinity-enhanced neutralizing antibody against the membrane-proximal external region of human immunodeficiency virus type 1 gp41 recognizes an epitope between those of 2F5 and 4E10.
    Nelson JD, Brunel FM, Jensen R, Crooks ET, Cardoso RM, Wang M, Hessell A, Wilson IA, Binley JM, Dawson PE, Burton DR, Zwick MB.
    J Virol; 2007 Apr 30; 81(8):4033-43. PubMed ID: 17287272
    [Abstract] [Full Text] [Related]

  • 14. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
    Veiga AS, Pattenden LK, Fletcher JM, Castanho MA, Aguilar MI.
    Chembiochem; 2009 Apr 17; 10(6):1032-44. PubMed ID: 19283693
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of a novel multi-immunogen vaccine strategy for targeting 4E10/10E8 neutralizing epitopes on HIV-1 gp41 membrane proximal external region.
    Banerjee S, Shi H, Banasik M, Moon H, Lees W, Qin Y, Harley A, Shepherd A, Cho MW.
    Virology; 2017 May 17; 505():113-126. PubMed ID: 28237764
    [Abstract] [Full Text] [Related]

  • 16. Structure-guided alterations of the gp41-directed HIV-1 broadly neutralizing antibody 2F5 reveal new properties regarding its neutralizing function.
    Guenaga J, Wyatt RT.
    PLoS Pathog; 2012 May 17; 8(7):e1002806. PubMed ID: 22829767
    [Abstract] [Full Text] [Related]

  • 17. Prolonged exposure of the HIV-1 gp41 membrane proximal region with L669S substitution.
    Shen X, Dennison SM, Liu P, Gao F, Jaeger F, Montefiori DC, Verkoczy L, Haynes BF, Alam SM, Tomaras GD.
    Proc Natl Acad Sci U S A; 2010 Mar 30; 107(13):5972-7. PubMed ID: 20231447
    [Abstract] [Full Text] [Related]

  • 18. Immunogenic properties of a trimeric gp41-based immunogen containing an exposed membrane-proximal external region.
    Habte HH, Banerjee S, Shi H, Qin Y, Cho MW.
    Virology; 2015 Dec 30; 486():187-97. PubMed ID: 26454663
    [Abstract] [Full Text] [Related]

  • 19. Anti-HIV-1 antibodies 2F5 and 4E10 interact differently with lipids to bind their epitopes.
    Franquelim HG, Chiantia S, Veiga AS, Santos NC, Schwille P, Castanho MA.
    AIDS; 2011 Feb 20; 25(4):419-28. PubMed ID: 21245727
    [Abstract] [Full Text] [Related]

  • 20. Evolution of antibody landscape and viral envelope escape in an HIV-1 CRF02_AG infected patient with 4E10-like antibodies.
    Dieltjens T, Heyndrickx L, Willems B, Gray E, Van Nieuwenhove L, Grupping K, Vanham G, Janssens W.
    Retrovirology; 2009 Dec 14; 6():113. PubMed ID: 20003438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.